Humana

Preço: 379.22

Empresa e modelo de negócios

Humana Inc. is a healthcare company that provides health insurance and related services. Its core products include Medicare Advantage plans, Medicaid services, and individual and group health insurance plans. Major business segments consist of Retail, Group and Specialty, and Healthcare Services. The primary revenue sources are premiums from health insurance policies and government contracts for Medicare and Medicaid services.

Perfil de investimento

Humana's stock is positioned for balanced investors, offering moderate growth potential alongside a dividend yield. The company's stable revenue growth and consistent earnings performance suggest a reliable investment profile. It may appeal to those seeking a combination of capital appreciation and income generation.

Site oficial

Métricas fundamentais (experimental)

EPS (TTM) — lucro por ação dos últimos 12 meses, $: 9.38 OK
Receita QoQ — crescimento da receita trimestre contra trimestre: 21.9% ↑
Surpresa de EPS: 3.4% em linha
Volatilidade 20d: 2.4% estável
Dividend yield: 1.2% moderado última data ex-dividendo: 2026-06-26

Dados FMP / FinFeed atualizados: 2026-06-13

Impacto da previsão

limitado

Preço-alvo elevado · Mizuho Securities · válido até 2026-07-08 · atualizado 2026-06-13

Alvo +2.8% preenchimento do alvo 97.2%

Reação D5 pendente · D10 pendente recente confirmado · confiança do mercado

Impacto Potencial 0 · Risco 0 preço próximo do alvo

Rec.: Comprar Potencial: 75 Risco: 30 Atualizado: 2026-06-13 02:55

Como a recomendação funciona

Por que a IA pensa assim:

Strong momentum and solid fundamentals support growth potential.

Acompanhar no portfólio

Gráfico de preço

Recomendação da IA Previsão do analista Evento de calendário Sinal positivo Sinal negativo Neutro / atualização Manter / informativo B My buy S My sell

Mudanças na recomendação da IA

Data	Antes	Depois	Motivo
2026-05-24 02:41	Manter	Comprar	Strong growth and positive momentum support bullish outlook.
2026-05-16 02:41	Comprar	Manter	Strong momentum and solid earnings growth support bullish outlook.
2026-05-08 15:14	—	Comprar	Strong fundamentals and positive momentum support growth outlook.
2026-05-05 02:54	Manter	Comprar	Компания показывает сильный рост выручки и положительную динамику акций за последние 20 и 60 дней. Умеренный риск связан с недавним снижением цены за 120 дней.
2026-04-09 02:57	Vender	Manter	Несмотря на недавний рост акций, компания испытывает значительное снижение на более длительных временных интервалах. Учитывая текущие показатели и неопределенность в секторе здравоохранения, рекомендуется удерживать акци
2026-03-23 07:38	Manter	Vender	Компания Humana демонстрирует значительное снижение цен за последние два месяца, что указывает на высокие риски. Однако, дивидендная доходность и небольшое превышение ожиданий по прибыли могут поддерживать интерес инвест
2026-03-14 07:42	Vender	Manter	Компания Humana демонстрирует значительное снижение цен за последние месяцы, что указывает на высокие риски. Однако стабильная дивидендная доходность и положительный EPS могут поддерживать интерес инвесторов.
2026-01-28 08:34	Manter	Vender	Существенное падение акций компании за последние месяцы указывает на высокие риски, а отсутствие данных о прибыли и доходах делает ситуацию еще более неопределенной.

Previsões de analistas

Data	Analista	Action	Alvo	Preço na época
2026-06-08 11:27	Mizuho Securities	Preço-alvo elevado	335 → 390	350.08
2026-06-04 11:50	Morgan Stanley	Preço-alvo elevado	217 → 249	327.54
2026-06-03 11:35	Bernstein	Preço-alvo elevado	288 → 425	320.88
2026-06-01 11:27	Truist Financial	Preço-alvo elevado	270 → 320	305.42
2026-05-26 12:58	Barclays	Preço-alvo elevado	180 → 344	300.86
2026-05-22 11:13	UBS	Preço-alvo elevado	262 → 320	303.68
2026-05-20 10:45	Mizuho Securities	Preço-alvo elevado	290 → 335	310.55
2026-05-20 09:42	Deutsche Bank	Rating elevado	— → 441	310.55
2026-05-15 10:30	Morgan Stanley	Preço-alvo elevado	146 → 217	301.35
2026-05-13 10:42	Piper Sandler	Preço-alvo elevado	182 → 254	295.35
2026-05-01 11:55	Raymond James	Preço-alvo elevado	230 → 260	236.44
2026-04-30 13:10	RBC Capital	Preço-alvo elevado	189 → 246	240.92
2026-04-30 13:05	Deutsche Bank	Preço-alvo elevado	180 → 235	241.1
2026-04-30 11:59	Oppenheimer	Preço-alvo elevado	250 → 260	242.68

Dow Jones Industrial Average Hits Record High as Health-Care Stocks Lead Market Gains

06/05/2026, 05:34 AM business review healthcare UnitedHealth Humana Centene Eli Lilly

Despite a decline in chip stocks, the U.S. stock market saw significant gains, with the Dow Jones Industrial Average reaching a new record, driven largely by strong performance in the health-care sector.

Stocks Surge and Decline Midday: MGM Resorts, Zoom Communications, Nvidia, and Others Report Significant Movements

06/01/2026, 10:35 AM business review software consumer Zoom Communications Microsoft Nvidia Veeva Systems Dell Technologies Viasat Humana MGM HP

Several companies experienced significant stock movements, driven by acquisition offers, earnings reports, and new product announcements, which could influence investor sentiment and market dynamics.